Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials
INTRODUCTION Section: ChooseTop of pageAbstractINTRODUCTION <<METHODSRESULTSDISCUSSIONREFERENCES Clinical trials investigating novel treatments for pancreatic ductal adenocarcinoma (PDAC) are troubled with under-representation of diverse participants. After adjusting for disease prevalence, Black, Asian […]